WeChat Mini Program

Old Version Features

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Quality of Life (qol) and Symptom Burden in Patients (pts) with Advanced Melanoma During the Treatment-Free Interval (TFI) after Discontinuation of Nivolumab (NIVO) or NIVO Plus Ipilimumab (IPI).

Fiona Taylor,Meredith M. Regan,Dirk Schadendorf,Michael B. Atkins,Rachael Lawrance,Alejandro Moreno-Koehler,Andriy Moshyk,Sumati Rao,Corey Ritchings,Srividya Kotapati,Jennifer Lord-Bessen,Jasmine I. Rizzo,David F. McDermott,Mark R. Middleton

JOURNAL OF CLINICAL ONCOLOGY（2019）

Cited 0|Views29

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined